| 000 | 01706 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517161250.0 | ||
| 264 | 0 | _c20180702 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a2211-3436 | ||
| 024 | 7 |
_a10.1007/s13402-017-0332-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShek, Felix H | |
| 245 | 0 | 0 |
_aSerine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma. _h[electronic resource] |
| 260 |
_bCellular oncology (Dordrecht, Netherlands) _cOct 2017 |
||
| 300 |
_a443-456 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCadherins _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xgenetics |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aSignal Transduction _xgenetics |
| 650 | 0 | 4 |
_aTrypsin Inhibitor, Kazal Pancreatic _xblood |
| 650 | 0 | 4 |
_abeta Catenin _xgenetics |
| 700 | 1 | _aLuo, Ruibang | |
| 700 | 1 | _aLam, Brian Y H | |
| 700 | 1 | _aSung, Wing Kin | |
| 700 | 1 | _aLam, Tak-Wah | |
| 700 | 1 | _aLuk, John M | |
| 700 | 1 | _aLeung, Ming Sum | |
| 700 | 1 | _aChan, Kin Tak | |
| 700 | 1 | _aWang, Hector K | |
| 700 | 1 | _aChan, Chung Man | |
| 700 | 1 | _aPoon, Ronnie T | |
| 700 | 1 | _aLee, Nikki P | |
| 773 | 0 |
_tCellular oncology (Dordrecht, Netherlands) _gvol. 40 _gno. 5 _gp. 443-456 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s13402-017-0332-x _zAvailable from publisher's website |
| 999 |
_c27293688 _d27293688 |
||